Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Case Rep ; 18(1): 220, 2024 May 04.
Article in English | MEDLINE | ID: mdl-38702820

ABSTRACT

BACKGROUND: Peripheral ossifying fibroma is a nonneoplastic inflammatory hyperplasia that originates in the periodontal ligament or periosteum in response to chronic mechanical irritation. Peripheral ossifying fibroma develops more commonly in young females as a solitary, slow-growing, exophytic nodular mass of the gingiva, no more than 2 cm in diameter. While various synonyms have been used to refer to peripheral ossifying fibroma, very similar names have also been applied to neoplastic diseases that are pathologically distinct from peripheral ossifying fibroma, causing considerable nomenclatural confusion. Herein, we report our experience with an unusual giant peripheral ossifying fibroma with a differential diagnostic challenge in distinguishing it from a malignancy. CASE PRESENTATION: A 68-year-old Japanese male was referred to our department with a suspected gingival malignancy presenting with an elastic hard, pedunculated, exophytic mass 60 mm in diameter in the right maxillary gingiva. In addition to computed tomography showing extensive bone destruction in the right maxillary alveolus, positron emission tomography with computed tomography revealed fluorodeoxyglucose hyperaccumulation in the gingival lesion. Although these clinical findings were highly suggestive of malignancy, repeated preoperative biopsies showed no evidence of malignancy. Since even intraoperative frozen histological examination revealed no malignancy, surgical resection was performed in the form of partial maxillectomy for benign disease, followed by thorough curettage of the surrounding granulation tissue and alveolar bone. Histologically, the excised mass consisted primarily of a fibrous component with sparse proliferation of atypical fibroblast-like cells, partly comprising ossification, leading to a final diagnosis of peripheral ossifying fibroma. No relapse was observed at the 10-month follow-up. CONCLUSIONS: The clinical presentation of giant peripheral ossifying fibromas can make the differential diagnosis from malignancy difficult. Proper diagnosis relies on recognition of the characteristic histopathology and identification of the underlying chronic mechanical stimuli, while successful treatment mandates complete excision of the lesion and optimization of oral hygiene. Complicated terminological issues associated with peripheral ossifying fibroma require appropriate interpretation and sufficient awareness of the disease names to avoid diagnostic confusion and provide optimal management.


Subject(s)
Fibroma, Ossifying , Gingival Neoplasms , Humans , Fibroma, Ossifying/surgery , Fibroma, Ossifying/pathology , Fibroma, Ossifying/diagnostic imaging , Male , Aged , Diagnosis, Differential , Gingival Neoplasms/pathology , Gingival Neoplasms/surgery , Gingival Neoplasms/diagnostic imaging , Gingival Neoplasms/diagnosis , Maxillary Neoplasms/pathology , Maxillary Neoplasms/surgery , Maxillary Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Maxilla/pathology , Maxilla/diagnostic imaging , Maxilla/surgery
2.
Oncol Rep ; 34(2): 771-8, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26043676

ABSTRACT

Epithelial-mesenchymal transition (EMT) is a crucial event required for the invasion and progression of carcinogenesis, inducing stem-like properties in epithelial cells. In the present study, the expression of BMI1, which controls self-renewal in stem cells, as well as that of ZEB1, a transcription factor that regulates EMT, was evaluated for its role in EMT and the carcinogenic processes of tongue squamous cell carcinoma (TSCC). Collagen invasion assays using two TSCC cells and 64 tongue specimens (32 carcinomas and 32 dysplasias) were employed and analyzed in the present study. We assessed the protein and mRNA expression levels of BMI1, ZEB1, vimentin and E-cadherin in the two cell lines and tumor tissues. The protein and mRNA expression of BMI1 and ZEB1 occurred at the invasion of TSCC. The elevated levels of BMI1 and ZEB1 were accompanied by the downregulation of E-cadherin and upregulation of vimentin at the invasive front, indicative of EMT in vitro and in vivo. The results showed that BMI1 and ZEB1 are important factors in association with the promotion of EMT and invasion of TSCC.


Subject(s)
Carcinoma, Squamous Cell/genetics , Homeodomain Proteins/biosynthesis , Mitogen-Activated Protein Kinase 7/biosynthesis , Tongue Neoplasms/genetics , Transcription Factors/biosynthesis , Adult , Aged , Aged, 80 and over , Cadherins/biosynthesis , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Epithelial-Mesenchymal Transition , Female , Gene Expression Regulation, Neoplastic , Homeodomain Proteins/genetics , Humans , Male , Middle Aged , Mitogen-Activated Protein Kinase 7/genetics , Tongue Neoplasms/pathology , Transcription Factors/genetics , Vimentin/biosynthesis , Zinc Finger E-box-Binding Homeobox 1
3.
Pathol Int ; 58(8): 524-8, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18705774

ABSTRACT

Cystadenoma is a relatively rare benign epithelial tumor of the salivary glands, and described herein is an additional case. A 51-year-old Japanese man had noticed a mass of the left hard palate 25 years previously. Macroscopically, the resected specimen was a multicystic lesion. Histologically, the tumor was composed of bilayered columnar epithelium with cystic change and partial solid growth of glandular structures with clear cells. The tumor cells had mild cellular atypia, but the tumor lacked papillary growth and a fibrous capsule. Immunohistochemistry was positive for cytokeratins, epithelial membrane antigen, MUC1, MUC4 and MUC6, but negative for myoepithelial markers, MUC2, MUC5AC and MUC5B. Such MUC expression patterns suggested that cystadenoma occurs from excretory ducts.


Subject(s)
Cystadenoma/pathology , Mucins/analysis , Palatal Neoplasms/pathology , Palate, Hard/pathology , Biomarkers, Tumor/analysis , Cystadenoma/chemistry , Cystadenoma/surgery , Humans , Immunohistochemistry , Male , Middle Aged , Palatal Neoplasms/chemistry , Palatal Neoplasms/surgery , Palate, Hard/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...